The Science Behind Anti-VEGF Therapy

The retina — the light-sensitive tissue lining the back of the eye — depends on a delicate network of healthy blood vessels that deliver the oxygen and nutrients it needs to function. When certain diseases disrupt that supply, the eye responds by growing new blood vessels. Rather than restoring healthy circulation, these vessels are often fragile and prone to leaking fluid or blood, which can damage the retina and threaten vision.

Anti-VEGF therapy is designed to interrupt this process at its source, making it one of the most effective treatments available for several common retinal conditions. Here's a closer look at how these medications work and why they have become a cornerstone of modern retinal care.

What Is VEGF?

Vascular endothelial growth factor (VEGF) is a protein the body uses to stimulate the formation of new blood vessels. This process is known as neovascularization, and it naturally occurs to repair wounds and restore circulation after injury. When the body produces excess amounts of VEGF, however, neovascularization can become a serious problem.

Several retinal diseases cause chronic inflammation and oxygen deprivation, which triggers retinal cells to continually release VEGF in an effort to improve blood flow to the affected tissue. However, excessive VEGF activity promotes the formation of fragile, poorly formed blood vessels that leak into the surrounding tissue. This can cause swelling, bleeding, and scarring that quickly damages the cells necessary for vision.

How Anti-VEGF Medications Work

Anti-VEGF drugs bind directly to VEGF molecules within the eye, blocking the signal that triggers abnormal growth. As VEGF activity decreases, existing abnormal vessels begin to regress, leakage gradually subsides, and new vessels are prevented from growing.

The medications are delivered through an injection placed into the vitreous, which is the gel-like substance that fills the interior of the eye. This allows the therapy to remain targeted to the retina, limiting its effects on the rest of the body.

Retinal Conditions Treated with Anti-VEGF Therapy

Anti-VEGF medications are used across a range of retinal diagnoses that trigger abnormal neovascularization. This can include:

• Wet Age-Related Macular Degeneration (AMD), in which abnormal blood vessels grow beneath the macula—the central region of the retina responsible for sharp, detailed vision.
• Diabetic Retinopathy (DR), which occurs when chronically elevated blood sugar levels damage the walls of retinal blood vessels, prompting the growth of new, fragile blood vessels
• Retinal Vein Occlusion (RVO), which occurs when one of the retinal veins becomes blocked and disrupts blood flow to the retina. In response, the retina releases increased amounts of VEGF, creating blood vessels that contribute to swelling within the macula.

Why Are Multiple Anti-VEGF Injections Necessary?

One of the most common questions patients have after starting anti-VEGF therapy is how long they will need to continue. Most retinal diseases treated with anti-VEGF injections will require ongoing management, set to a schedule that will vary between patients.

While anti-VEGF injections control disease activity, they do not eliminate the underlying condition causing excess VEGF production. Meaning, as the medication wears off, VEGF levels can rise again. For this reason, treatment typically begins with an induction phase of three monthly injections. From there, your retina specialist will assess how the retina is responding and gradually extend the time between treatments depending on the progress. Many patients reach intervals of six to twelve weeks between injections.

Advanced Retinal Care in Texas

The introduction of anti-VEGF therapy fundamentally changed retinal care. Before these medications became available, treatment options only focused on slowing vision loss. Today, many patients receiving anti-VEGF injections can maintain functional vision for years, or even experience meaningful improvements.

While every patient's condition is different, the greatest benefits are often achieved through early diagnosis, individualized treatment plans, and consistent follow-up. Regular retinal examinations and advanced imaging allow retina specialists to monitor how the eye is responding to treatment and adjust injection schedules as needed to provide the best possible long-term outcomes.

As one of the largest retina-only practices in the country and an active research participant that helps bring new treatments like anti-VEGF medications to market, Retina Consultants of Texas combines innovation with decades of clinical expertise to deliver individualized, evidence-based retinal care. If you have been referred for anti-VEGF therapy or want to learn more about your treatment options, schedule a consultation with our team today.